SJS Investment Consulting’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$927 Buy
271
+266
+5,320% +$827 ﹤0.01% 2056
2026
Q1
$12 Buy
+5
New +$12 ﹤0.01% 2417
2025
Q2
Sell
-154
Closed -$1.39K 1628
2025
Q1
$1.39K Hold
154
﹤0.01% 877
2024
Q4
$2.01K Sell
154
-1
-0.6% -$13 ﹤0.01% 698
2024
Q3
$2.43K Sell
155
-12
-7% -$182 ﹤0.01% 706
2024
Q2
$2.25K Sell
167
-3
-2% -$61 ﹤0.01% 657
2024
Q1
$4.71K Buy
170
+3
+2% +$67 ﹤0.01% 479
2023
Q4
$3.22K Buy
167
+151
+944% +$2.73K ﹤0.01% 494
2023
Q3
$259 Buy
16
+3
+23% +$53 ﹤0.01% 1409
2023
Q2
$248 Buy
13
+11
+550% +$196 ﹤0.01% 1362
2023
Q1
$30 Sell
2
-8
-80% -$143 ﹤0.01% 1549
2022
Q4
$195 Buy
10
+2
+25% +$39 ﹤0.01% 1416
2022
Q3
$0 Buy
+8
New +$247 ﹤0.01% 1405
2022
Q1
$0 Buy
+2
New +$86 ﹤0.01% 1165

Other funds holding ACH

SJS Investment Consulting's ACH Position: Q2 2026 in Review

SJS Investment Consulting increased its Accendra Health (ACH) stake by 5,320% in Q2 2026, buying an estimated $827 and bringing the position to 271 shares worth $927. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

SJS Investment Consulting first reported a position in ACH in Q1 2022 and has held it in 14 quarters since. The position peaked at $4.71K in Q1 2024. 20 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • SJS Investment Consulting held 271 shares of Accendra Health worth $927 as of Q2 2026.
  • SJS Investment Consulting bought 266 Accendra Health shares in Q2 2026, an estimated $827.
  • Accendra Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2056 holding.
  • SJS Investment Consulting first reported a position in Accendra Health in Q1 2022 and has held it in 14 quarters since.
  • SJS Investment Consulting's Accendra Health position peaked at $4.71K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.